Literature DB >> 19184578

Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects.

Ravi Gupta1, Vivek Kumar, Kalpana Luthra, Basudeb Banerjee, Manjeet Singh Bhatia.   

Abstract

Nitric oxide plays an important role in the pathogenesis of migraine as well as tension-type headache. Studies suggest that the expression of molecules involved in the pathogenesis of headache, i.e., nitric oxide and interleukin, is influenced by apolipoprotein E (APOE) and is gene specific. Hence, we hypothesized that APOE polymorphism may be associated with migraine as well as tension-type headache.The study sample comprised of three groups: migraineurs, tension-type headache subjects as well as a healthy control group. A total of 50 subjects in each group were included after screening for the inclusion and exclusion criteria. None of the subjects was a blood relative of any other subject included in the present study. Their venous blood was drawn and stored at -20 degrees C. Genomic DNA extraction was performed with a commercial kit and simple sequence-specific primer PCR was performed to assess the APOE polymorphism. Data were analyzed with the help of SPSS V11.0 for Windows. chi(2) test and logistic regression analysis were run. The results of the study showed that APOE epsilon2 gene increases the risk of migraine as compared to the control group and the tension-type headache group (OR=4.85; 95% CI=1.92-12.72; P<0.001 and OR=2.31; 95% CI=1.08-4.94; P=0.01, respectively). Interestingly, APOE epsilon4 gene was protective against migraine as well as tension-type headache. This study shows that APOE epsilon2 gene increases the risk of migraine, while APOE epsilon4 gene is protective against migraine and tension-type headache. Further research is required to confirm the findings of the present study in a larger sample and to elucidate the role of APOE polymorphism in headache.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184578      PMCID: PMC3451647          DOI: 10.1007/s10194-008-0094-y

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  41 in total

1.  Simple sequence-specific-primer-PCR method to identify the three main apolipoprotein E haplotypes.

Authors:  Panagiotis Pantelidis; Michelle Lambert-Hammill; Anthony S Wierzbicki
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

2.  Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India.

Authors:  G R Chandak; M Uma Sridevi; C J Vas; D M Panikker; L Singh
Journal:  Hum Biol       Date:  2002-10       Impact factor: 0.553

3.  Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells.

Authors:  Bernd L Fiebich; Klaus Lieb; Stefanie Engels; Michael Heinrich
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

4.  Apolipoprotein E isoform mediated regulation of nitric oxide release.

Authors:  Candice M Brown; Elizabeth Wright; Carol A Colton; Patrick M Sullivan; Daniel T Laskowitz; Michael P Vitek
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

5.  Value of neuroimaging in the evaluation of neurologically normal children with recurrent headache.

Authors:  Füsun Korkmaz Alehan
Journal:  J Child Neurol       Date:  2002-11       Impact factor: 1.987

6.  Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study.

Authors:  K Luthra; K Prasad; P Kumar; M Dwivedi; R M Pandey; N Das
Journal:  Clin Genet       Date:  2002-07       Impact factor: 4.438

7.  APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response.

Authors:  John R Lynch; Wen Tang; Haichen Wang; Michael P Vitek; Ellen R Bennett; Patrick M Sullivan; David S Warner; Daniel T Laskowitz
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

8.  Absence of linkage between the interleukin-6 gene (-174 G/C) polymorphism and migraine.

Authors:  Innocenzo Rainero; Giuliana Salani; Walter Valfrè; Lidia Savi; Chiara Rivoiro; Margherita Ferrero; Lorenzo Pinessi; Luigi M E Grimaldi
Journal:  Neurosci Lett       Date:  2003-06-12       Impact factor: 3.046

9.  APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.

Authors:  Carol A Colton; Candice M Brown; Danielle Cook; Leila K Needham; Qing Xu; Meggan Czapiga; Ann M Saunders; Donald E Schmechel; Karima Rasheed; Michael P Vitek
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

10.  Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport.

Authors:  M Czapiga; C A Colton
Journal:  J Neuroimmunol       Date:  2003-01       Impact factor: 3.478

View more
  5 in total

1.  Association of the Apolipoprotein E polymorphism with migraine: a meta-analysis.

Authors:  Jiayin Miao; Feng Wang; Weihong Zheng; Xiaorong Zhuang
Journal:  BMC Neurol       Date:  2015-08-12       Impact factor: 2.474

2.  Migraine: is it related to hormonal disturbances or stress?

Authors:  Rachna Parashar; Payal Bhalla; Nirendra K Rai; Abhijit Pakhare; Rashmi Babbar
Journal:  Int J Womens Health       Date:  2014-10-24

3.  Serum apolipoprotein E may be a novel biomarker of migraine.

Authors:  Naoki Yuasa; Eiichiro Nagata; Natsuko Fujii; Masatoshi Ito; Hideo Tsukamoto; Shunya Takizawa
Journal:  PLoS One       Date:  2018-01-22       Impact factor: 3.240

4.  Diagnostic Accuracy of Serum Calcitonin Gene-Related Peptide and Apolipoprotein E in Migraine: A Preliminary Study.

Authors:  Rabia Latif; Nazish Rafique; Lubna Al Asoom; Ahmed A Alsunni; Ayad Mohammed Salem; Dinah Abdulhadi AlNoaimi; Wasan Mohammed AlHarbi; Ahad Yasir Shaikh; Shoug Abdullah AlRaddadi; Leena Abdulrahman AlMuhaish; Dana Almohazey; Sayed Abdulazeez; J Francis Borgio
Journal:  Int J Gen Med       Date:  2021-03-12

5.  Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache.

Authors:  Lanfranco Pellesi; Elisa Bellei; Simona Guerzoni; Maria Michela Cainazzo; Carlo Baraldi; Emanuela Monari; Luigi Alberto Pini
Journal:  BMC Neurol       Date:  2019-10-17       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.